Cyclin d2 is essential for BCR-mediated proliferation and CD5 B cell development

International Immunology

Volumn 12, Issue 5, 2000, Pages 631-638

  Solvason, Nanette ^a,f   Wu, Wei Wei ^a   Parry, David ^a   Mahony, Daniel ^a   Lam, Eric W F ^b   Glassford, Janet ^b   Klaus, Gerry G B ^c   Sicinski, Piotr ^d,e   Weinberg, Robert ^e   Liu, Yong Jun ^a   Howard, Maureen ^a,f   Lees, Emma ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Anti Ig; B CLL; B1 B cells; Cell cycle; Chronic lymphocytic leukemia

Indexed keywords

BCR ABL PROTEIN; CD40 ANTIGEN; CD5 ANTIGEN; CYCLIN D2; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 17544395426     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.5.631     Document Type: Article

References (42)

1. 1/S transition. Cancer Surv. 29:7.
2. Sherr, C. J. 1995. D-type cyclins. Trends Biochem Sci. 20:187.
3. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323.
4. 1 phase in rodent fibroblasts. Genes Dev. 7:1559.
5. Sicinski, P., Donaher, J. L., Geng, Y., Parker, S. B., Gardner, H., Park, M. Y., Robker, R. L., Richards, J. S., McGinnis, L. K., Biggers, J. D., Eppig, J. J., Bronson, R. T., Elledge, S. J. and Weinberg, R. A. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470.
6. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J. and Weinberg, R. A. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621.
7. Lahti, J. M., Li, H. and Kidd, V. J. 1997. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem. 272:10859.
8. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
9. 1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027.
10. Meyyappan, M., Wong, H., Hull, C. and Riabowol, K. T. 1998. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol. 18:3163.
11. Taieb, F., Chartrain, I., Chevalier, S., Haccard, O. and Jessus, C. 1997. Cyclin D2 arrests Xenopus early embryonic cell cycles. Exp. Cell Res. 237:338.
12. Li, Z., Hromchak, R. and Bloch, A. 1997. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim. Biophys. Acta 1356:149.
13. Ganter, B., Fu, S. L. and Lipsick, J. S. 1998. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain EMBO J. 17:255.
14. Solvason, N., Wu, W. W., Kabra, N., Wu, X., Lees, E. and Howard, M. C. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
15. Tanguay, D. A. and Chiles, T. C. 1996. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539.
16. 1 cell cycle stage following delivery of complete versus partial activation stimuli. Mol. Immunol. 33:1139.
17. Pokrovskaja, K., Ehlin-Henriksson, B., Bartkova, J., Bartek, J., Scuderi, R., Szekely, L., Wiman, K. G. and Klein, G, 1996. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Cell Growth Different. 7:1723.
18. Palmero, I., Holder, A., Sinclair, A. J., Dickson, C and Peters, G. 1993. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8:1049.
19. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M. and Arnold, A. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350:512.
20. Iida, S., Seto, M., Yamamoto, K. and Ueda, R. 1992. Overexpression of PRAD1 gene in B-cell malignancy with t(11; 14)(q13;q32) translocation. Nippon Rinsho 50:1374.
21. Dighiero, G. 1997. Chronic lymphocytic leukemia treatment. Hematol. Cell. Ther. 39:59.
22. Delmer, A., Ajchenbaum-Cymbalista, F., Tang, R., Ramond, S., Faussat, A. M., Marie, J. P. and Zittoun, R. 1995. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 85:.
23. Solvason, N., Wu, W. W., Kabra, N., Wu, X., Lees, E. and Howard, M. C. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
24. Coffman, R. L. and Carty, J. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 136:949
25. Solvason, N., Wu, W. W., Kabra, N., Lund-Johansen, F., Roncarolo, M. G., Behrens, T. W., Grillot, D. A., Nunez, G., Lees, E. and Howard, M. 1998. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187:1081.
26. Julius, M. H., Heusser, C. H. and Hartmann, K. U. 1984. Induction of resting B cells to DNA synthesis by soluble monoclonal anti-immunoglobulin. Eur. J. Immunol. 14:753.
27. Tarakhovsky, A. 1997. Bar Mitzvah for B-1 cells: how will they grow up? J. Exp. Med. 185:981.
28. Burrows, P. D. and Cooper, M. D. 1997. B cell development and differentiation. Curr. Opin. Immunol. 9:239.
29. 1/S transition of B precursor cells. Int. Immunol. 8:317.
30. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. and Swat, W. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470.
31. Sato, S., Miller, A. S., Howard, M. C. and Tedder, T. F. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278.
32. Kerner, J. D., Appleby, M. W., Mohr, R. N., Chien, S., Rawlings, D. J., Maliszewski, C. R., Witte, O. N. and Perlmutter, R. M. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301.
33. Khan, W. N., Nilsson, A., Mizoguchi, E., Castigli, E., Forsell, J., Bhan, A. K., Geha, R., Sideras, P. and Alt, F. W. 1997. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9:395.
34. Solvason, N., Lehuen, A. and Kearney, J. F. 1991. An embryonic source of Ly1 but not conventional B cells. Int. Immunol. 3:543.
35. Kantor, A. B., Stall, A. M., Adams, S., Watanabe, K. and Herzenberg, L. A. 1995. De novo development and self-replenishment of B cells. Int. Immunol. 7:55.
36. Wortis, H. H. 1992. Surface markers, heavy chain sequences and B cell lineages. Int. Rev. Immunol. 8:235.
37. Briles, D. E., Forman, C., Hudak, S. and Claflin, J. L. 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1177.
38. + B lymphocytes. Int. Immunol. 2:515.
39. Perlmutter, R. M., Hansburg, D., Briles, D. E., Nicolotti, R. A. and Davie, J. M. 1978. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:566.
40. Kroese, F. G., de Waard, R. and Bos, N. A. 1996. B-1 cells and their reactivity with the murine intestinal microflora. Semin. Immunol. 8:11.
41. Dighiero, G. 1998. Autoimmunity and B-cell malignancies. Hematol. Cell. Ther. 40:1.
42. Caligaris-Cappio, F. 1997. Relationship between autoimmunity and immunodeficiency in CLL. Hematol. Cell. Ther. 39:24